Search and Browse
Download
Enter Data
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128404 (US8802695, 20) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet  | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM ... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128406 (US8802695, 22) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM ... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128395 (US8802695, 11) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM ... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128394 (US8802695, 10) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM ... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128407 (US8802695, 23) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM ... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128399 (US8802695, 15) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM ... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128407 (US8802695, 23) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | 7.3 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM A... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128398 (US8802695, 14) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM ... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128396 (US8802695, 12) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM ... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128400 (US8802695, 16) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM ... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128406 (US8802695, 22) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | 7.3 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM A... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128395 (US8802695, 11) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | 7.3 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM A... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128410 (US8802695, 26) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 9 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM ... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128399 (US8802695, 15) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | 7.3 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM A... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128404 (US8802695, 20) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | 7.3 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM A... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128408 (US8802695, 24) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM ... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128410 (US8802695, 26) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | 7.3 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM A... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128402 (US8802695, 18) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 14 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM ... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128398 (US8802695, 14) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 16 | n/a | n/a | n/a | n/a | 7.3 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM A... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128412 (US8802695, 28) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 16 | n/a | n/a | n/a | n/a | 7.3 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM A... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128402 (US8802695, 18) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 17 | n/a | n/a | n/a | n/a | 7.3 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM A... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128408 (US8802695, 24) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 18 | n/a | n/a | n/a | n/a | 7.3 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM A... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128403 (US8802695, 19) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 19 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM ... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128414 (US8802695, 31) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 19 | n/a | n/a | n/a | n/a | 7.3 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM A... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128400 (US8802695, 16) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | 7.3 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM A... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128396 (US8802695, 12) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | 7.3 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM A... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128403 (US8802695, 19) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 29 | n/a | n/a | n/a | n/a | 7.3 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM A... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128413 (US8802695, 29) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 38 | n/a | n/a | n/a | n/a | 7.3 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM A... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128416 (US8802695, 33) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 41 | n/a | n/a | n/a | n/a | 7.3 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM A... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128397 (US8802695, 13) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM ... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128409 (US8802695, 25) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 60 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM ... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128394 (US8802695, 10) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 62 | n/a | n/a | n/a | n/a | 7.3 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM A... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128397 (US8802695, 13) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 64 | n/a | n/a | n/a | n/a | 7.3 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM A... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128401 (US8802695, 17) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 69 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM ... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128393 (US8802695, 9) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 81 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The test compounds (2.5 μL) dissolved in DMSO were added to wells containing 37.5 μL of the reaction solution (25 mM HEPES (pH 7.5), 10 mM ... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128415 (US8802695, 32) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 122 | n/a | n/a | n/a | n/a | 7.3 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM A... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128409 (US8802695, 25) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 146 | n/a | n/a | n/a | n/a | 7.3 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM A... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128401 (US8802695, 17) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 214 | n/a | n/a | n/a | n/a | 7.3 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM A... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128393 (US8802695, 9) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 237 | n/a | n/a | n/a | n/a | 7.3 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM A... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128411 (US8802695, 27) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 528 | n/a | n/a | n/a | n/a | 7.3 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM A... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Mitogen-activated protein kinase kinase kinase 5 (Homo sapiens (Human)) | BDBM128405 (US8802695, 21) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.24E+4 | n/a | n/a | n/a | n/a | 7.3 | 25 |
Takeda Pharmaceutical Company Limited US Patent | Assay Description The inhibitory properties of compounds to ASK1 may be determined using a white 384-well-plate format under the following reaction conditions: 25 nM A... | US Patent US8802695 (2014) BindingDB Entry DOI: 10.7270/Q27W69WD | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
